Jade Biosciences, Inc. JBIO 深 沪
等待开盘 07-15 09:30:00 美东时间
21.355
+0.055
+0.26%
华盛通- 最 高21.90
- 今 开21.33
- 成交量 59.95万股
- 最 低 20.91
- 昨 收 21.30
- 总市值 13.00亿
- 52周最高 28.00
- 市盈率 静 --
- 换手率 0.99%
- 52周最低 6.67
- 委 比 -45.79%
- 总股本 6085.99万
- 历史最高 1050.525
- 量 比 1.09
- 振 幅 4.65%
- 历史最低 -40.25
- 每 手 1
- 风险率 5.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 特朗普政府加码量子计算！QNT涨超13%；Backblaze涨超43%，与CoreWeave签署一项3.35亿美元协议
特朗普政府加码量子计算！ARQQ大涨超35%，QNT涨超13%；Backblaze涨超43%，与CoreWeave签署一项3.35亿美元的数据存储协议>>
06-24 15:51
美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45
UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $45.
06-15 20:55
Stock Market Today: S&P 500 Futures Fall, Dow Gains As House Challenges Trump's Military Authority—Broadcom, CrowdStrike, Lululemon In Focus
U.S. stock futures were mixed on Thursday, after a lower close on Wednesday, as the Nasdaq 100 and S&P 500 advanced, but the Dow Jones rose.
06-04 17:12
Reported Earlier, Jade Biosciences Prices $150M Stock Offering Of 10M Shares at $15 Each
Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the pricing of a public
06-04 16:20
Ciena, Docusign And 3 Stocks To Watch Heading Into Thursday
Stocks to watch: CIEN, DOCU, LULU, report earnings today. MRAAF introduces world's first 100Vdc 2.2μF chip MLCC for auto safety.
06-04 13:24
Jade Biosciences Reveals Proposed Underwritten Public Offering; No Size Disclosed
Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it intends to offer and
06-04 04:05
美股大行评级 | 潜在涨幅43%，慧与获11家大行集体上调目标价；最高300美元，Credo获9家大行集体上调目标价
今日重点评级关注：Ascendiant Capital：维持Genasys"买入"评级，目标价从5.5美元升至6美元；Citizens：维持Abivax"跑赢大市"评级，目标价从131美元升至187美元
06-03 11:17
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Why Is Jade Biosciences Stock Trading Lower On Monday?
Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.
06-02 01:59
